105 related articles for article (PubMed ID: 31006224)
1. [Identification of circulating tumor cells in peripheral blood for gliomas by detection of aneuploid cells].
Li MX; Ren XH; Jiang HH; Yang KY; Lin S; Cui Y
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1184-1188. PubMed ID: 31006224
[No Abstract] [Full Text] [Related]
2. Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.
Li M; Gao F; Ren X; Dong G; Chen H; Lin AY; Wang DD; Liu M; Lin PP; Shen S; Jiang H; Yang C; Zhang X; Zhao X; Zhu Q; Li M; Cui Y; Lin S
Cancer Sci; 2022 Oct; 113(10):3535-3546. PubMed ID: 35940591
[TBL] [Abstract][Full Text] [Related]
3. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
Ge F; Zhang H; Wang DD; Li L; Lin PP
Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
[TBL] [Abstract][Full Text] [Related]
4. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
5. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells.
Lin PP; Gires O; Wang DD; Li L; Wang H
Sci Rep; 2017 Aug; 7(1):9789. PubMed ID: 28852197
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous
Yao H; Wang Z; Yang J; Xu X; Song Y
Ann Transl Med; 2021 Dec; 9(24):1772. PubMed ID: 35071466
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H
Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196
[TBL] [Abstract][Full Text] [Related]
10. Characterization of circulating tumor cells by fluorescence in situ hybridization.
Swennenhuis JF; Tibbe AG; Levink R; Sipkema RC; Terstappen LW
Cytometry A; 2009 Jun; 75(6):520-7. PubMed ID: 19291800
[TBL] [Abstract][Full Text] [Related]
11. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells.
Sheng Y; Wang T; Li H; Zhang Z; Chen J; He C; Li Y; Lv Y; Zhang J; Xu C; Wang Z; Huang C; Wang L
Oncotarget; 2017 Jan; 8(5):8801-8806. PubMed ID: 28187533
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
13. Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer.
Cheng H; Wang S; Luan W; Ye X; Dou S; Tang Z; Zhu H; Lin PP; Li Y; Cui H; Chang X
Chin J Cancer Res; 2021 Apr; 33(2):256-270. PubMed ID: 34158744
[TBL] [Abstract][Full Text] [Related]
14. [Detection and clinical significance of circulating tumor cells in osteosarcoma using immunofluorescence combined with in situ hybridization].
Zhang HQ; Li MH; Wang Z; Lan PH; Lu YJ; Chen GJ; Wang L
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):485-489. PubMed ID: 28728292
[No Abstract] [Full Text] [Related]
15. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells.
Lin PP
Clin Transl Med; 2015 Dec; 4(1):38. PubMed ID: 26718583
[TBL] [Abstract][Full Text] [Related]
16. [Detection of Circulating Tumor Cells in Bladder Cancer by Subtraction Enrichment and Immunostaining-fluorescence
Yang YB; Bai YJ; Tang Y; Liu ZH; Wei Q; Han P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):605-609. PubMed ID: 28752983
[TBL] [Abstract][Full Text] [Related]
17. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
18. Aneuploid CTC and CEC.
Lin PP
Diagnostics (Basel); 2018 Apr; 8(2):. PubMed ID: 29670052
[TBL] [Abstract][Full Text] [Related]
19. Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer.
Chen Y; Yang Z; Wang Y; Wang J; Wang C
BMC Cancer; 2019 Jul; 19(1):651. PubMed ID: 31269908
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
